CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 134 enrolled
Drug / intervention
Moderate neuromuscular block +1 moredrug
Likely dose
Deep neuromuscular block 4 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04022733
NCT04022733N/ACompleted
CompareCT.gov

A Double-blind, Randomized Study to Compare the Remifentanil Requirements in Deep Versus Moderate Neuromuscular Blocks During the Surgical Pleth Index-guided Analgesia in Patients Undergoing General Anesthesia for Laparoscopic Herniorrhaphy

Ajou University School of Medicine·interventional·Posted Jul 17, 2019·Updated Nov 9, 2023

In Brief

A clinical study evaluating Moderate neuromuscular block and Deep neuromuscular block for Hernia Abdominal Wall. Completed, enrolled 134 participants across 1 site.

Detailed Summary

The primary purpose of this study is to compare the remifentanil requirements in deep versus moderate neuromuscular blocks during the surgical pleth index -guided anesthesia in patients undergoing laparoscopic herniorrhaphy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHernia Abdominal Wall
CountriesSouth Korea
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJul 17, 2019
Enrollment StartOct 30, 2019
Primary CompletionAug 3, 2021
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 7.0 years ago

Interventions

Moderate neuromuscular blockdrug

maintaining of moderate neuromuscular block (train-of-four count 1-2) during surgery, reversal using neostigmine 50 ug/kg and glycopyrrolate 10 ug/kg

Deep neuromuscular blockdrug

maintaining of deep neuromuscular block (posttetanic count 1-2) during surgery, reversal using sugammadex 4 mg/kg based on actual body weight